brain cancer

Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
Siren emerges from stealth with plans to marry gene therapy to cancer immunotherapy
BioPharma Dive
Siren Biotechnology
gene therapy
cancer immunotherapy
brain cancer
eye cancer
Flag link:
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Novartis' Tafinlar/Mekinist combo scores new indication in pediatric brain cancer
Endpoints
Novartis
Tafinlar
Mekinist
pediatric
brain cancer
FDA
Flag link:
NW Bio reports positive top-line results from phase 3 glioblastoma trial
NW Bio reports positive top-line results from phase 3 glioblastoma trial
Labiotech.eu
Northwest Biotherapeutics
DCVax
clinical trials
glioblastoma
brain cancer
vaccines
Flag link:
VBI Vaccines gets orphan drug designation for glioblastoma therapy
VBI Vaccines gets orphan drug designation for glioblastoma therapy
Pharmaceutical Business Review
VBI Vaccines
FDA
VBI-1901
glioblastoma
brain cancer
vaccines
Flag link:
Two days after showing strong pediatric cancer data, Day One taps $150M in public capital
Two days after showing strong pediatric cancer data, Day One taps $150M in public capital
Endpoints
Day One Biopharmaceuticals
funding
tovorafenib
pediatric cancer
brain cancer
Flag link:
A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug
A new day for pediatric cancer patients: Day One's share price doubles on initial data for brain tumor drug
Fierce Biotech
Day One Biopharmaceuticals
tovorafenib
pediatric
pediatric cancer
brain cancer
pediatric low-grade glioma
Flag link:
Ultrasound Drug-Device Offers Diffuse Treatment for Glioblastoma Multiforme
Ultrasound Drug-Device Offers Diffuse Treatment for Glioblastoma Multiforme
Medical Devices and Diagnostics Industry
Alpheus Medical
devices
Medtech
drug-device combos
glioblastoma multiforme
brain cancer
Flag link:
Imvax raises $112M to advance brain cancer cell therapy
Imvax raises $112M to advance brain cancer cell therapy
Fierce Biotech
Imvax
brain cancer
glioblastoma
Flag link:
Bayer-backed Century buys Empirica to create brain cancer CAR-Ts
Bayer-backed Century buys Empirica to create brain cancer CAR-Ts
Fierce Biotech
Century Therapeutics
Empirica
cell therapies
brain cancer
glioblastoma
CAR-T
Flag link:
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
Agios up as FDA gives Thermo Fisher glioma test breakthrough status
Pharmaforum
Agios Pharmaceuticals
FDA
vorasidenib
brain cancer
glioma
Flag link:
Scorpion Venom Could Improve Immuno-Oncology Therapies in Brain Cancer
Scorpion Venom Could Improve Immuno-Oncology Therapies in Brain Cancer
BioSpace
brain cancer
drug development
CAR-T
City of Hope
scorpion venom
Flag link:
A Blood Test for Brain Cancer with a Dash of AI Added
A Blood Test for Brain Cancer with a Dash of AI Added
Medical Devices and Diagnostics Industry
diagnostics
brain cancer
ClinSpec Diagnostics
artificial intelligence
Flag link:
Tocagen's brain cancer treatment fails late-stage study, shares crash
Tocagen's brain cancer treatment fails late-stage study, shares crash
Reuters
Tocagen
clinical trials
brain cancer
Toca 511
Flag link:
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Strike three: Bristol-Myers’ third I/O shot at glioblastoma misses as Opdivo flops yet again on key endpoint
Endpoints
Bristol-Myers Squibb
Opdivo
glioblastoma
brain cancer
clinical trials
Flag link:
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Karyopharm drug tested in ‘industry-first’ approach to brain cancer
Pharmaforum
Karyopharm
Xpovio
brain cancer
Selinexor
clinical trials
glioblastoma
Flag link:
Bayer’s regorafenib kicks off brain cancer platform trial
Bayer’s regorafenib kicks off brain cancer platform trial
Pharmaforum
Bayer
brain cancer
clinical trials
GBM
regorafenib
Flag link:
No news is bad news for Tocagen
No news is bad news for Tocagen
BioPharma Dive
Tocagen
Toca 511
Toca FC
brain cancer
clinical trials
Flag link:
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
Roche, Bayer unveil brain tumor data for NTRK inhibitors ahead of ASCO
BioCentury
Roche
Bayer
brain cancer
entrectinib
Vitrakvi
Flag link:
Two papers open door to T cell brain entry for glioblastoma therapy
Two papers open door to T cell brain entry for glioblastoma therapy
BioCentury
T-cells
glioblastoma
brain cancer
Nature
Flag link:
Freshly IPO’d Tocagen tweaks brain cancer gene therapy test
Freshly IPO’d Tocagen tweaks brain cancer gene therapy test
Fierce Biotech
Tocagen
brain cancer
gene therapy
Toca 511
Toca FC
Flag link:

Pages